NCT02449291View on ClinicalTrials.gov

Study of APD421 as PONV Treatment (no Prior Prophylaxis)

PHASE3CompletedINTERVENTIONAL

Enrollment

568

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG

APD421

DRUG

Placebo

Trial Locations (4)

33136

Jackson Memorial Hospital, Miami

43210

Ohio State University, Columbus

Unknown

CHU de Hautepierre, Strasbourg

Universität Heidelberg, Heidelberg

Sponsors

Lead Sponsor

Acacia Pharma Ltd

All Listed Sponsors

lead

Acacia Pharma Ltd

INDUSTRY